ÂÜÀòÂÒÂ×

Rick Coope currently serves as General Manager for the UK, Ireland, and the Nordics at Stemline Therapeutics since October 2022. Prior to this role, Rick held several prominent positions at Clovis Oncology from July 2018 to October 2022, including Vice President and Head of Commercial North Europe, where responsibilities included the successful launch of Rubraca in key European markets. Rick's extensive experience at Daiichi Sankyo spanned various roles from Country General Manager to Regional Business Director, focusing on strategic leadership and business development across Europe. An educational background in Pharmacology was obtained with a BSc Hons from the University of Leeds between 1992 and 1995.